DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
TREATMENT PROTOCOL S-122
ALLERGIC REACTION / ANAPHYLAXIS
Date: 7/1/2025 Page 1 of 1
BLS ALS
1 Infection control: If concerned about aerosolized infectious exposure, substitute with MDI, if available
• Ensure patent airway
• O2 saturation PRN
• O2 and/or ventilate PRN
• Attempt to identify allergen and route
(injected, ingested, absorbed, or inhaled)
• Remove allergen (e.g., stinger, injection
mechanism), if possible
• Epinephrine auto-injector 0.3 mg IM x1
OR
Assist patient to self-medicate own
prescribed epinephrine auto-injector or
albuterol MDI once only. BH contact
required for additional dose(s)
• Monitor/ECG
• IV/IO Ⓐ
• Capnography
Allergic reaction (skin signs only)
• Urticaria (hives, rash)
• Erythema (flushing)
• Pruritus (itching)
Allergic reaction treatment
• Diphenhydramine 50 mg IV/IM
Suspected anaphylaxis reaction
• Respiratory: throat tightness, hoarse voice, wheezing/stridor,
cough, SOB
• Cardiovascular: fainting, dizziness, tachycardia, low BP
• GI: nausea, vomiting, abdominal cramping
• Tissues: angioedema of eyelids, lips, tongue, face
Anaphylaxis treatment
• Epinephrine 1:1,000 (1 mg/mL) 0.5 mg IM, MR x2 q5 min Ⓐ
then
• Diphenhydramine 50 mg IV/IM
If respiratory involvement1
• Albuterol/Levalbuterol 6 mL via nebulizer, MR Ⓐ
• Ipratropium bromide 2.5 mL 0.02% via nebulizer
added to first dose of albuterol/levalbuterol
Severe anaphylaxis or inadequate response to treatment
• 500 mL fluid bolus IV/IO MR to maintain SBP ≥90 mmHg Ⓐ
• Push-dose epinephrine 1:100,000 (0.01 mg/mL)
1 mL IV/IO, MR q3 min, titrate to SBP ≥90 mmHg or
improvement in status
Push-dose epinephrine mixing instructions
1. Remove 1 mL normal saline (NS) from the 10 mL
NS syringe
2. Add 1 mL of epinephrine 1:10,000 (0.1 mg/mL) to 9 mL
NS syringe
The mixture now has 10 mL of epinephrine at 0.01 mg/mL
(10 mcg/mL) concentration.

